HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BodyArmor Not ‘Only Sports Drink’ After Gatorade Challenge, Keeps ‘Reconsider’ Choice Suggestion

Executive Summary

NAD concludes using “Only Sports Drink” above descriptions of BodyArmor drinks in less prominent text misleadingly implies the products alone have no artificial sweeteners, flavors or dyes or have “potassium packed electrolytes.” Industry self-regulation group rejects Gatorade challenges that BodyArmor social media videos made false and misleading comparisons between the sports drink lines.

You may also be interested in...



Gatorade Laughs Last About BodyArmor Claims

Coca-Cola's BA Sports argued video comparing its BodyArmor and PepsiCo business Stokely-Van Camp’s Gatorade flavors was a “social media joke” not an ad claim.

BodyArmor Rejects NAD Ad Claims Decision Following Gatorade Challenge

BA Sports stands by claims comparing BodyArmor SuperDrink to Gatorade and will not pull or change ads as an industry self-regulation group recommends. Firm's response could draw FTC attention, but previously ignoring the group's recommendations apparently has not prompted FTC enforcement.

Bodyarmor Rejects NAD’s ‘Upgrade’ Claim Critique

Gatorade sports drinks Stokely-Van Camp challenged that Bodyarmor Nutrition was noncompliant with NAD’s April 2014 finding that its ads combined claims that are supported individually in such a way that they created unsupported comparative claims

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS150537

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel